MAILLAND, Federico F,SCARCI, Francesco F,CASERINI, Maurizio M,.美拉德,.斯卡爾奇,.卡塞里尼
申请号：
HK16104187.7
公开号：
HK1216151A
申请日:
2016.04.13
申请国别(地区):
HK
年份:
2016
代理人:
摘要：
The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
